Ingenuity® Systems is excited to announce the Ingenuity Fall 2013 Grant Program! | all4bioinformatics
Breaking News
Loading...

Monday, 1 July 2013

Ingenuity® Systems is excited to announce the Ingenuity Fall 2013 Grant Program!

Applicants may submit proposals to receive either a limited IPA® license or free sample(s) analysis using Ingenuity Variant Analysis™.
Ingenuity Systems is awarding six grants, one for each topic. The deadline for grant submission is August 23, 2013.
apply now


Eligible Entrants:
  • Topics of grants you can apply to:
    • IPA
      • Host-response in infectious diseases
      • Role of microRNA in tumor progression
      • Insights from RNA-sequencing data
    • Variant Analysis
      • Multi-kindred studies of rare diseases
      • Drug response in large-scale cohorts
      • Interpretation of genomes using pathway-level burden tests


Timeline:

  • Opening date: June 10, 2013
  • Application due date: August 23, 2013
  • Award date*: October 22 - 26, 2013 (at the annual ASHG conference in Boston, MA)
*All entrants will be contacted prior to public announcement of the winners indicated status.


Guidelines for Grant Proposals:
All proposals must conform to the following guidelines to be eligible for consideration:
  • Proposals must apply to one of the specified topics
  • Proposals must be received by Ingenuity Systems by August 23, 2013, 11:59PM PST
  • Proposals must include specific research aims (one to two sentences)
  • Proposals must include a summary of the significance of your research project (no more than four sentences)
  • Proposals must include a summary of the method and design in your research (no more than 500 characters)
Click here for the complete terms and conditions.


Selection Criteria:
Proposals will be reviewed based on the following criteria:
  • Importance
  • Approach
  • Environment

Questions? Submit all questions to customer-rewards@ingenuity.com

google+

linkedin

About Author
  • Donec sed odio dui. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Sed posuere consecteturDonec sed odio dui. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Read More

    0 comments:

    POST A COMMENT

     

    Gallery

    About

    About Us